Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus
Fierce Biotech
Tue, 12/20/22 - 11:17 am
Tags:
Kite Pharma
,
Gilead Sciences
,
M&A
,
CAR-T
,
Tmunity
,
Carl June
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
Tags:
clinical trials
,
Acadia Pharmaceuticals
,
Argenx
,
Arrowhead Pharmaceuticals
,
Biomarin
,
BioNTech
,
Daiichi Sankyo
,
Day One
,
EQRx
,
Fate Therapeutics
,
FibroGen
,
Gilead Sciences
,
Idorsia
,
Immunogen
,
Intellia Therapeutics
,
Karuna Therapeutics
,
Moderna Therapeutics
,
Regeneron
,
Roche
,
Travere Therapeutics
,
Vaxcyte
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
breast cancer
,
antibody-drug conjugate
,
clinical trials
,
Gilead Sciences
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Tags:
Gilead Sciences
,
Kite Pharma
,
Arcellx
,
clinical trials
,
Multiple Myeloma
,
cell therapy
,
JNJ
,
Legend Biotech
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
NASDAQ.com
Thu, 12/8/22 - 10:03 am
Tags:
Daiichi Sankyo
,
Gilead Sciences
,
Yescarta
,
Japan
Federal claims court rules in favor of Gilead in CDC Truvada patent case
Endpoints
Thu, 12/1/22 - 07:08 pm
Tags:
Gilead Sciences
,
Truvada
,
PrEP
,
HIV
,
CDC
,
patents
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
Tags:
FDA
,
Mirati Therapeutics
,
Gilead Sciences
,
Coherus Biosciences
,
Roche
,
Biogen
,
TG Therapeutics
,
Ipsen
,
Novartis
,
BeiGene
,
Cytokinetics
Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease
Fierce Biotech
Mon, 11/28/22 - 07:37 pm
Tags:
Gilead Sciences
,
Arcus Biosciences
,
clinical trials
,
domvanalimab
,
zimberelimab
,
non-small cell lung cancer
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Tags:
Gilead Sciences
,
Kite Pharma
,
Bristol Myers Squibb
,
cell therapy
,
legal
,
CAR-T
,
Yescarta
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Tags:
Gilead Sciences
,
ARCUS
,
clinical trials
,
Merck
,
Keytruda
,
domvanalimab
,
zimberelimab
,
non-small cell lung cancer
Gilead's Hopes for HDV Approval Delayed after CRL
BioSpace
Sun, 10/30/22 - 04:15 pm
Tags:
Gilead Sciences
,
hepatitis D
,
FDA
,
buleviritide
Gilead, working to improve cancer cell therapy, partners with California startup
BioPharma Dive
Thu, 10/20/22 - 11:28 pm
Tags:
Gilead Sciences
,
Refuge Biotechnologies
,
CAR-T
Gilead touts Veklury resilience against mutated coronavirus, plots phase 3 for new COVID oral antiviral
Fierce Pharma
Wed, 10/19/22 - 11:03 am
Tags:
Gilead Sciences
,
COVID-19
,
clinical trials
,
Veklury
Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal
BioSpace
Mon, 10/17/22 - 10:26 am
Tags:
Gilead Sciences
,
Macrogenics
,
hematological cancers
,
drug development
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
Tags:
FDA
,
Phanes
,
Pfizer
,
GSK
,
Regeneron
,
Eagle Pharmaceuticals
,
Galactin Therapeutics
,
BridgeBio
,
Gilead Sciences
,
Covis Pharma
,
scPharmaceuticals
,
XACT Robotics
,
BioMind Labs
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
Tags:
FDA
,
Biogen
,
Eisai
,
Alzheimer's disease
,
Gilead Sciences
,
HIV
,
Mirati Therapeutics
,
lung cancer
,
lecanemab
,
lenacapavir
,
adagrasib
After a rocky few months, Gilead's Trodelvy keeps recent winning streak rolling with priority review
Fierce Pharma
Tue, 10/11/22 - 04:08 pm
Tags:
Gilead Sciences
,
breast cancer
,
Trodelvy
,
ESMO
,
FDA
,
priority review
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
Tags:
M&A
,
Pfizer
,
Global Blood Therapeutics
,
Amgen
,
ChemoCentryx
,
Novo Nordisk
,
Forma
,
Alcon
,
Aerie Pharmaceuticals
,
Gilead Sciences
,
MiroBio
Gilead targets 'large-scale' HIV drugs counterfeiting scheme as judge orders asset freeze
Fierce Pharma
Thu, 09/29/22 - 07:40 pm
Tags:
Gilead Sciences
,
HIV
,
drug counterfeiting
,
legal
Study identifies Covid-19 patients with mutations indicating remdesivir resistance
Endpoints
Wed, 09/28/22 - 10:27 pm
Tags:
Gilead Sciences
,
remdesivir
,
COVID-19
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.